Adequate protein intake, hydration, and proper nutrition planning can help
In some cases, GLP-1s outperform traditional treatments like metformin or spironolactone, giving new hope to patients confronting metabolic and reproductive issues
The most common way that semaglutide is injected is through a subcutaneous injection
The rationale for combination builds upon the documented mechanisms of each component
While GLP-1s have gained attention in recent years for their ability to quickly reduce weight, their metabolic and cardiovascular benefits may be even more important
Treatment discontinuations were higher, ranging from 12% to 17% of patients with semaglutide and 14% to 22% of patients with placebo, except in the STEP 4 study, which featured the 20-week run-in and where treatment discontinuations were 6% with semaglutide and 12% with placebo